Gender-related differences in chronic kidney disease-associated vascular calcification risk and potential risk mediators: a scoping review

PY Wu, SY Lee, KV Chang, CT Chao, JW Huang - Healthcare, 2021 - mdpi.com
Vascular calcification (VC) involves the deposition of calcium apatite in vascular intima or
media. Individuals of advanced age, having diabetes mellitus or chronic kidney disease …

Cardiovascular safety of anti-sclerostin therapy in chronic kidney disease

D Cejka - Metabolites, 2021 - mdpi.com
The significance of sclerostin for bone and cardiovascular health in patients with chronic
kidney disease (CKD) is complex and incompletely understood. Experimental evidence …

Sclerostin and TNF-related weak inducer of apoptosis: can they be important in the patients with glomerulonephritis?

H Ozer, İ Baloglu, T Aykut, MA Demirci… - Revista da Associação …, 2023 - SciELO Brasil
SUMMARY OBJECTIVE: Sclerostin is a protein produced by osteocytes, kidneys, and
vascular cells and has many effects on kidney and vascular structures. Soluble TNF-related …

Evaluation of aortic biomechanics in patients with aortic disease via imaging: A review

Y Wang, M Gong - Journal of Clinical Ultrasound, 2022 - Wiley Online Library
As a bridge between the heart and the arteries, the aorta plays an important role in the
cardiovascular system. The morbidity and mortality of aortic disease are extremely high …

Anti-Sklerostin-Therapie aus nephrologischer Sicht–mit einem Fokus auf kardiovaskuläre Sicherheit

D Cejka - Journal für Mineralstoffwechsel & Muskuloskelettale …, 2021 - Springer
Die Zusammenhänge zwischen Sklerostin und Knochendichte, Gefäßverkalkung,
kardiovaskulärer Morbidität und Mortalität bei chronischer Niereninsuffizienz („chronic …